CEO Roundtable
New Pharma-Biotech Deal Structures Are Yielding Interesting Value Propositions
Thursday, October 20
3:30 p.m. - 4:30 p.m.
Pacific Heights
This panel discussed the recent deals and deal structures that have emerged as pharma companies are aggressively seeking to build upon their early- and late-stage pipelines, and biotech companies are getting a cold shoulder from the public markets.
Moderator:
- John E. Wehrli, Senior Associate, Latham & Watkins LLP
Panelists:
- David J. Earp, JD, PhD, Chief Patent Counsel, Senior VP Business Development, Geron Corporation
- Chris Lehman, Principal, Collabrity, Inc.
- Kathleen Sereda Glaub, President, Plexxikon, Inc.